All In Biotech

Drug Trial Radar · NCT00003906

Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women

Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer

Last checked: Nov 19, 2026Latest source record: Oct 6, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 19,747 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

19,747

Actual

Start

May 1999

Primary completion

Dec 2005

Study completion Aug 2012

Sponsor

Lead sponsor
NSABP Foundation IncResearch network
Sponsor type
Research network
Collaborators
National Cancer Institute (NCI); Eli Lilly and Company; AstraZeneca
First posted
Jan 27, 2003

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Prevention
Who can join
Female only, from 35 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

RATIONALE: Estrogen can stimulate the growth of breast cancer cells. Hormone therapy using raloxifene and tamoxifen may fight breast cancer by blocking the uptake of estrogen by the tumor cells. PURPOSE: Randomized double-blinded clinical trial to compare the effectiveness of raloxifene with that of tamoxifen in preventing breast cancer in postmenopausal women.

Conditions

  • Breast Cancer

Interventions

  • RaloxifeneDrug

    60 mg/day plus placebo for 5 years

  • TamoxifenDrug

    20 mg/day plus placebo for 5 years

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of invasive breast cancer; superiority of one of the therapies.Time frame: Time from randomization to the occurance of invasive breast cancer.

Locations

516 sites in 3 countries. Site status is shown where the registry gives one.

  • Comprehensive Cancer Institute

    Huntsville, Alabama

  • MBCCOP - Gulf Coast

    Mobile, Alabama

  • Providence Alaska Medical Center

    Anchorage, Alaska

  • CCOP - Western Regional, Arizona

    Phoenix, Arizona

  • CCOP - Mayo Clinic Scottsdale Oncology Program

    Scottsdale, Arizona

  • Arizona Cancer Center at University of Arizona Health Sciences Center

    Tucson, Arizona

  • Breast Associates

    Fayetteville, Arkansas

  • Surgical Associates

    Fort Smith, Arkansas

  • Northeast Arkansas Clinic

    Jonesboro, Arkansas

  • Arkansas Cancer Research Center at University of Arkansas for Medical Sciences

    Little Rock, Arkansas

  • Kaiser Permanente Medical Center - Anaheim/Orange County

    Anaheim, California

  • Kaiser Permanente Medical Center - Baldwin Park

    Baldwin Park, California

  • Kaiser Permanente Medical Center - Bellflower

    Bellflower, California

  • Alta Bates Comprehensive Cancer Center

    Berkeley, California

  • Providence Saint Joseph Medical Center - Burbank

    Burbank, California

  • Mills-Peninsula Health Services

    Burlingame, California

  • Enloe Cancer Center at Enloe Medical Center

    Chico, California

  • Mount Diablo Medical Center

    Concord, California

  • Corona Regional Medical Center

    Corona, California

  • City of Hope Comprehensive Cancer Center

    Duarte, California

  • Scripps Memorial Hospitals-Stevens Cancer Center - Encinitas

    Encinitas, California

  • North Bay Cancer Center

    Fairfield, California

  • Kaiser Permanente Medical Center - Fontana

    Fontana, California

  • Crosson Cancer Center at St. Jude Medical Center

    Fullerton, California

  • Glendale Memorial Hospital Comprehensive Cancer Center

    Glendale, California

  • Oncology/Hematology Associates

    Granada Hills, California

  • Marin General Hospital Cancer Institute

    Greenbrae, California

  • Kaiser Permanente Medical Center - Harbor City

    Harbor City, California

  • Hemet Valley Medical Center

    Hemet, California

  • Rebecca and John Moores UCSD Cancer Center

    La Jolla, California

  • Valley Tumor Medical Group

    Lancaster, California

  • Loma Linda University Cancer Institute at Loma Linda University Medical Center

    Loma Linda, California

  • Todd Cancer Institute at Long Beach Memorial Medical Center

    Long Beach, California

  • Pacific Shores Medical Group Comprehensive Hematology-Oncology Services - Long Beach

    Long Beach, California

  • Kaiser Permanente Medical Center - Los Angeles

    Los Angeles, California

  • USC/Norris Comprehensive Cancer Center and Hospital

    Los Angeles, California

  • Cecilia Gonzalez De La Hoya Cancer Center at White Memorial Medical Center

    Los Angeles, California

  • Kaiser Foundation Hospital - West Los Angeles

    Los Angeles, California

  • St. Vincent Medical Center - Los Angeles

    Los Angeles, California

  • Jonsson Comprehensive Cancer Center, UCLA

    Los Angeles, California

Showing 40 of 516 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.